(BCAT) BlackRock Capital - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US09260U1097

Equities, Debt Securities, Leverage, Convertibles, Options

Stock: Asset Management & Custody Banks
Age 5.3y
MCap 1,514m
Avg Vol 605K (8.86M USD)
Beta 0.534
Volatility 9.65%

EPS (Earnings per Share)

EPS (Earnings per Share) of BCAT over the last years for every Quarter: "2020-12": null, "2021-06": 1.39, "2021-12": -0.31, "2022-06": -3.06, "2022-12": 0.15, "2023-12": null, "2024-12": null,
EPS CAGR: -94.86%
EPS Trend: -46.8%
Qual. Beats: 0

Revenue

Revenue of BCAT over the last years for every Quarter: 2020-12: null, 2021-06: null, 2021-12: null, 2022-06: null, 2022-12: null, 2023-12: null, 2024-12: null,
Rev. CAGR: 0.00%
Qual. Beats: 0

Dividends

Dividend Yield 22.47%
Yield on Cost 5y 32.99%
Yield CAGR 5y 27.71%
Payout Consistency 92.1%
Payout Ratio 226.7%
Risk via 5d forecast
Volatility 9.65%
Value at Risk 5%th 15.9%
Relative Tail Risk 0.35%
Reward TTM
Sharpe Ratio 0.90
Alpha 4.87
CAGR/Max DD 1.28
Character TTM
Hurst Exponent 0.435
Beta 0.534
Beta Downside 0.531
Drawdowns 3y
Max DD 13.69%
Mean DD 1.94%
Median DD 1.24%

Description: BCAT BlackRock Capital January 16, 2026

BlackRock Capital Allocation Trust (NYSE: BCAT) is a U.S.-based common stock that operates within the Asset Management & Custody Banks sub-industry of the GICS classification. The fund’s mandate is to allocate capital across a diversified set of BlackRock-managed strategies, aiming to deliver long-term total return while maintaining a flexible, opportunistic investment approach.

Key metrics as of the latest filing show assets under management of roughly $1.2 billion, an expense ratio of 0.85 %, and a trailing-12-month dividend yield near 2.1 %. The trust’s performance is closely tied to macro-level drivers such as interest-rate trends (which influence fee structures for asset managers) and equity market volatility (which creates allocation opportunities across sectors). Additionally, the broader asset-management industry benefits from rising inflows into passive and ESG-focused products, a trend that can enhance BCAT’s underlying holdings.

For a deeper quantitative breakdown and scenario analysis, you may find ValueRay’s BCAT profile a useful next step.

Piotroski VR‑10 (Strict, 0-10) 7.5

Net Income (194.4m TTM) > 0 and > 6% of Revenue (6% = 11.9m TTM)
FCFTA 0.19 (>2.0%) and ΔFCFTA 10.32pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue -96.73% (prev -73.99%; Δ -22.75pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.19 (>3.0%) and CFO 354.9m > Net Income 194.4m (YES >=105%, WARN >=100%)
Net Debt (-6.30m) to EBITDA (194.4m) ratio: -0.03 <= 3.0 (WARN <= 3.5)
Current Ratio 0.03 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (104.8m) change vs 12m ago -3.11% (target <= -2.0% for YES)
Gross Margin 100.0% (prev 100.0%; Δ 0.0pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 10.01% (prev 9.93%; Δ 0.08pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 138.5 (EBITDA TTM 194.4m / Interest Expense TTM 1.40m) >= 6 (WARN >= 3)

Altman Z'' -0.52

(A) -0.10 = (Total Current Assets 6.30m - Total Current Liabilities 197.5m) / Total Assets 1.87b
(B) -0.04 = Retained Earnings (Balance) -79.8m / Total Assets 1.87b
(C) 0.10 = EBIT TTM 194.4m / Avg Total Assets 1.97b
(D) -0.36 = Book Value of Equity -79.8m / Total Liabilities 224.0m
Total Rating: -0.52 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 63.31

1. Piotroski 7.50pt
2. FCF Yield 23.50%
3. FCF Margin data missing
4. Debt/Equity data missing
5. Debt/Ebitda -0.03
6. ROIC - WACC (= 3.79)%
7. RoE 10.94%
8. Revenue Trend data missing
9. EPS Trend -46.77%

What is the price of BCAT shares?

As of January 17, 2026, the stock is trading at USD 14.80 with a total of 1,108,825 shares traded.
Over the past week, the price has changed by +2.42%, over one month by +5.26%, over three months by +6.17% and over the past year by +16.49%.

Is BCAT a buy, sell or hold?

BlackRock Capital has no consensus analysts rating.

What are the forecasts/targets for the BCAT price?

Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 21.2 42.9%

BCAT Fundamental Data Overview January 11, 2026

P/E Trailing = 9.5695
P/S = 9.4997
P/B = 0.9222
Revenue TTM = 197.7m USD
EBIT TTM = 194.4m USD
EBITDA TTM = 194.4m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = -6.30m USD (from netDebt column, last fiscal year)
Enterprise Value = 1.51b USD (1.51b + (null Debt) - CCE 3.88m)
Interest Coverage Ratio = 138.5 (Ebit TTM 194.4m / Interest Expense TTM 1.40m)
EV/FCF = 4.26x (Enterprise Value 1.51b / FCF TTM 354.9m)
FCF Yield = 23.50% (FCF TTM 354.9m / Enterprise Value 1.51b)
FCF Margin = 179.5% (FCF TTM 354.9m / Revenue TTM 197.7m)
Net Margin = 98.35% (Net Income TTM 194.4m / Revenue TTM 197.7m)
Gross Margin = 100.0% ((Revenue TTM 197.7m - Cost of Revenue TTM 0.0) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = 0.81 (Enterprise Value 1.51b / Total Assets 1.87b)
Interest Expense / Debt = unknown (Interest Expense 1.40m / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 153.6m (EBIT 194.4m * (1 - 21.00%))
Current Ratio = 0.03 (Total Current Assets 6.30m / Total Current Liabilities 197.5m)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = -0.03 (Net Debt -6.30m / EBITDA 194.4m)
Debt / FCF = -0.02 (Net Debt -6.30m / FCF TTM 354.9m)
Total Stockholder Equity = 1.78b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.85% (Net Income 194.4m / Total Assets 1.87b)
RoE = 10.94% (Net Income TTM 194.4m / Total Stockholder Equity 1.78b)
RoCE = 11.65% (EBIT 194.4m / Capital Employed (Total Assets 1.87b - Current Liab 197.5m))
RoIC = 11.68% (EBIT 194.4m / (Assets 1.87b - Curr.Liab 197.5m - Cash 3.88m))
WACC = 7.89% (E(1.51b)/V(1.51b) * Re(7.89%) + (debt-free company))
Discount Rate = 7.89% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -81.65 | Cagr: -1.26%
[DCF Debug] Terminal Value 81.62% ; FCFF base≈285.5m ; Y1≈352.1m ; Y5≈599.7m
Fair Price DCF = 98.99 (EV 10.37b - Net Debt -6.30m = Equity 10.37b / Shares 104.8m; r=7.89% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -46.77 | EPS CAGR: -94.86% | SUE: N/A | # QB: 0
Revenue Correlation: N/A | Revenue CAGR: 0.0% | SUE: N/A | # QB: 0

Additional Sources for BCAT Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle